CATALYST PHARMACEUTICALS, INC. — Form 4
Filed July 17, 2026 · analyzed by the Insider Agent
4
— Neutral
significance 20/100
What the filing says
Chief Financial Officer Kalb Michael Wayne (CPRX) disposed 647K shares (non-open-market). Non-market disposition.
Why this rating
Non-market disposition.
See more from July 17, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.